We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease
Dec 02
Indian (NIFTY) Pharma Industry Analysis
UpdatedDec 04, 2023
DataAggregated Company Financials
Companies158
- 7D1.8%
- 3M9.9%
- 1Y28.6%
- YTD33.2%
In the last week, the Pharma industry is up 1.8%, with Sun Pharmaceutical Industries up 3.0%. During this same period, the Aether Industries underperformed, falling 11%. This means that the industry has gained 29% over the past year. As for the next few years, earnings are expected to grow by 18% per annum.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 04 Dec 2023 | ₹14.3t | ₹3.4t | ₹395.1b | 31.6x | 36.2x | 4.2x |
| Wed, 01 Nov 2023 | ₹12.8t | ₹3.3t | ₹373.9b | 29.4x | 34.2x | 3.9x |
| Fri, 29 Sep 2023 | ₹13.0t | ₹3.3t | ₹369.5b | 29.8x | 35.1x | 4x |
| Sun, 27 Aug 2023 | ₹12.8t | ₹3.3t | ₹367.0b | 29.1x | 35x | 3.9x |
| Tue, 25 Jul 2023 | ₹12.3t | ₹3.2t | ₹342.4b | 26.1x | 35.9x | 3.9x |
| Thu, 22 Jun 2023 | ₹11.4t | ₹3.2t | ₹342.4b | 26.1x | 33.4x | 3.6x |
| Sat, 20 May 2023 | ₹10.3t | ₹3.1t | ₹308.1b | 26.6x | 33.3x | 3.3x |
| Mon, 17 Apr 2023 | ₹9.9t | ₹3.0t | ₹277.7b | 25x | 35.5x | 3.3x |
| Wed, 15 Mar 2023 | ₹9.3t | ₹3.0t | ₹277.5b | 23.5x | 33.4x | 3.1x |
| Fri, 10 Feb 2023 | ₹9.8t | ₹3.0t | ₹284.0b | 23.7x | 34.4x | 3.3x |
| Sun, 08 Jan 2023 | ₹9.9t | ₹2.9t | ₹274.9b | 26.8x | 36x | 3.5x |
| Tue, 06 Dec 2022 | ₹10.2t | ₹2.9t | ₹274.9b | 26.8x | 37.1x | 3.6x |
| Thu, 03 Nov 2022 | ₹10.5t | ₹2.8t | ₹262.7b | 24.3x | 40.1x | 3.8x |
| Sat, 01 Oct 2022 | ₹9.9t | ₹2.8t | ₹261.9b | 23.5x | 37.7x | 3.5x |
| Mon, 29 Aug 2022 | ₹9.7t | ₹2.8t | ₹261.9b | 23.4x | 36.9x | 3.5x |
| Wed, 27 Jul 2022 | ₹9.5t | ₹2.8t | ₹273.6b | 21.4x | 34.6x | 3.4x |
| Fri, 24 Jun 2022 | ₹9.1t | ₹2.8t | ₹273.8b | 20.2x | 33.2x | 3.3x |
| Sun, 22 May 2022 | ₹9.6t | ₹2.7t | ₹319.9b | 21.5x | 30.1x | 3.5x |
| Tue, 19 Apr 2022 | ₹10.2t | ₹2.7t | ₹338.0b | 24.1x | 30.1x | 3.8x |
| Thu, 17 Mar 2022 | ₹9.9t | ₹2.7t | ₹337.9b | 23.6x | 29.3x | 3.7x |
| Sat, 12 Feb 2022 | ₹10.1t | ₹2.7t | ₹341.1b | 23.6x | 29.5x | 3.7x |
| Mon, 10 Jan 2022 | ₹10.6t | ₹2.7t | ₹361.8b | 26.7x | 29.2x | 4x |
| Wed, 08 Dec 2021 | ₹10.0t | ₹2.7t | ₹360.3b | 23.2x | 27.6x | 3.7x |
| Fri, 05 Nov 2021 | ₹10.4t | ₹2.6t | ₹366.7b | 23.7x | 28.3x | 3.9x |
| Sun, 03 Oct 2021 | ₹11.0t | ₹2.6t | ₹376.2b | 25.6x | 29.2x | 4.2x |
| Tue, 31 Aug 2021 | ₹10.8t | ₹2.6t | ₹375.2b | 24.4x | 28.9x | 4.2x |
| Wed, 07 Jul 2021 | ₹10.7t | ₹2.6t | ₹371.5b | 24x | 28.9x | 4.2x |
| Sat, 10 Apr 2021 | ₹9.0t | ₹2.5t | ₹332.3b | 16.1x | 27.1x | 3.6x |
| Fri, 01 Jan 2021 | ₹9.3t | ₹2.5t | ₹320.8b | 19x | 29.1x | 3.8x |
Price to Earnings Ratio
35.8x
Current Industry PE
- Investors are optimistic on the Indian Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 36.2x which is higher than its 3-year average PE of 32.3x.
- The 3-year average PS ratio of 3.7x is lower than the industry's current PS ratio of 4.2x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 18% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 2.45% | |
| Healthcare | 2.15% | |
| Pharma | 1.84% | |
| Pharma | 1.84% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries | ₹1.23k | 3.0% +₹85.9b | 18.4% | PE34.6x | |
| 500257 Lupin | ₹1.30k | 4.3% +₹24.3b | 67.2% | PE44.3x | |
| 500420 Torrent Pharmaceuticals | ₹2.15k | 3.0% +₹20.9b | 32.8% | PE54.2x | |
| 500124 Dr. Reddy's Laboratories | ₹5.75k | 1.9% +₹17.4b | 27.4% | PE18.8x | |
| SUVENPHAR Suven Pharmaceuticals | ₹674.35 | 9.6% +₹15.0b | 44.3% | PE39.8x |